1AD1 Stock Overview Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
AddLife AB (publ) Competitors Price History & Performance
Summary of share price highs, lows and changes for AddLife Historical stock prices Current Share Price SEK 11.48 52 Week High SEK 14.74 52 Week Low SEK 8.15 Beta 1.34 1 Month Change 1.77% 3 Month Change -19.10% 1 Year Change 24.24% 3 Year Change -67.93% 5 Year Change 65.18% Change since IPO 80.79%
Recent News & Updates
New minor risk - Earnings quality Oct 24
Third quarter 2024 earnings released: EPS: kr0.20 (vs kr0.20 in 3Q 2023) Oct 23 AddLife AB (publ) to Report First Half, 2025 Results on Jul 15, 2025
Second quarter 2024 earnings released: EPS: kr0.59 (vs kr0.26 in 2Q 2023) Jul 16
AddLife AB (publ) to Report Q1, 2025 Results on Apr 25, 2025 Jun 27
Insufficient new directors Jun 02 See more updates
New minor risk - Earnings quality Oct 24
Third quarter 2024 earnings released: EPS: kr0.20 (vs kr0.20 in 3Q 2023) Oct 23 AddLife AB (publ) to Report First Half, 2025 Results on Jul 15, 2025
Second quarter 2024 earnings released: EPS: kr0.59 (vs kr0.26 in 2Q 2023) Jul 16
AddLife AB (publ) to Report Q1, 2025 Results on Apr 25, 2025 Jun 27
Insufficient new directors Jun 02
AddLife AB (publ) Approves Dividend, Payable on 16 May 2024 May 09
First quarter 2024 earnings released: EPS: kr0.51 (vs kr1.43 in 1Q 2023) Apr 24
AddLife AB (publ) to Report Fiscal Year 2024 Results on Feb 05, 2025 Apr 24
Independent Director recently bought €2.8m worth of stock Mar 13
AddLife AB (publ) to Report Fiscal Year 2023 Results on Apr 05, 2024 Mar 06
Dividend of kr0.50 announced Feb 12
Full year 2023 earnings released: EPS: kr1.56 (vs kr3.94 in FY 2022) Feb 03 AddLife AB (publ) to Report Q3, 2024 Results on Oct 23, 2024
Investor sentiment improves as stock rises 26% Nov 02
Third quarter 2023 earnings released Oct 28
AddLife AB (publ) to Report First Half, 2024 Results on Jul 15, 2024 Oct 27
Now 22% undervalued after recent price drop Oct 26
AddLife AB (publ), Annual General Meeting, May 08, 2024 Oct 20
New major risk - Share price stability Oct 06
Investor sentiment deteriorates as stock falls 33% Jul 21
New minor risk - Dividend sustainability Jul 20
Second quarter 2023 earnings released: EPS: kr0.27 (vs kr0.61 in 2Q 2022) Jul 14
Investor sentiment deteriorates as stock falls 15% Jun 21
Independent Director recently bought €1.0m worth of stock May 28
Addlife AB (Publ) Declares Dividend May 06
Investor sentiment improves as stock rises 22% May 03
Upcoming dividend of kr1.20 per share at 1.0% yield Apr 28
First quarter 2023 earnings released Apr 27
President & CEO recently bought €12k worth of stock Apr 02
President & CEO recently bought €10.0k worth of stock Mar 09
Full year 2022 earnings released: EPS: kr3.94 (vs kr6.02 in FY 2021) Feb 04
AddLife AB (publ) Proposes Dividend for the Year Ended December 31, 2022 Feb 03
Håkan Roos acquired a 0.246285% stake in AddLife AB (publ) for SEK 30 million. Nov 02
Third quarter 2022 earnings released Oct 28 AddLife AB (publ) to Report First Half, 2023 Results on Jul 14, 2023
AddLife AB (publ) to Report Q1, 2023 Results on Apr 26, 2023 Sep 30
Now 22% undervalued after recent price drop Aug 30
Second quarter 2022 earnings released Jul 16
Now 20% undervalued after recent price drop Jul 02
Investor sentiment deteriorated over the past week Jun 17
CFO & Business Area Manager of Medtech recently sold €808k worth of stock Jun 06
Addlife AB (Publ) Approves Dividend, Payable on 12 May 2022 May 06
Upcoming dividend of kr2.00 per share Apr 29 AddLife AB (publ) Appoints Fredrik Dalborg as President
Full year 2021 earnings released: EPS: kr6.02 (vs kr4.62 in FY 2020) Apr 03
AddLife AB (publ) (OM: ALIF B) acquired O'Flynn Medical Limited. Apr 03
Addlife AB (Publ) Proposes Dividend, Payable on 12 May 2022 Mar 31
Investor sentiment improved over the past week Mar 16
AddLife AB (publ) (OM:ALIF B) completed the acqusitions of Telia Health Monitoring. Mar 03
President & CEO recently bought €552k worth of stock Feb 08
Addlife AB (Publ) Proposes Dividend Feb 05
Addlife AB (Publ) Announces Step Down of Kristina Willgård as Chief Executive Officer Feb 04
AddLife AB (publ) (OM:ALIF B) completed the acquisition of MBA Incorporado S.A from Alantra Private Equity. Jan 22
Investor sentiment deteriorated over the past week Jan 11
Investor sentiment improved over the past week Dec 24
AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire MBA Incorporado S.A from Alantra Private Equity for approximately €110 million. Dec 23
AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Telia Health Monitoring. Dec 22
Investor sentiment deteriorated over the past week Dec 08
Beijing AddLife AB (publ) (OM:ALIF B) acquired Camanio AB from Brighter AB (publ) (OM:BRIG) for SEK 65 million. Dec 02
President & CEO recently sold €3.2m worth of stock Oct 30
Investor sentiment improved over the past week Oct 29
Third quarter 2021 earnings released Oct 23
Independent Chairman recently sold €1.1m worth of stock Sep 22
AddLife AB (publ) (OM:ALIF B) acquired Bio-Connect BV. Sep 02
Investor sentiment improved over the past week Aug 24
Independent Chairman recently sold €689k worth of stock Aug 08
Second quarter 2021 earnings released: EPS kr1.46 (vs kr1.07 in 2Q 2020) Jul 16
Investor sentiment improved over the past week Jul 12
Chief Financial Officer recently sold €1.4m worth of stock May 09
Independent Director has left the company May 08
AddLife AB (publ) Approves Dividend, Payable on 12 May 2021 May 06
First quarter 2021 earnings released Apr 30
Upcoming dividend of kr1.50 per share Apr 29
AddLife AB (Publ) Provides Earnings Guidance for 2021 Apr 13
Investor sentiment improved over the past week Apr 09
Full year 2020 earnings released: EPS kr4.62 (vs kr1.27 in FY 2019) Apr 03
New 90-day high: €17.50 Mar 04
Full year 2020 earnings released: EPS kr4.62 (vs kr1.27 in FY 2019) Feb 05
AddLife AB (publ) to Report Fiscal Year 2021 Results on Feb 03, 2022 Feb 04
New 90-day high: €16.04 Feb 03
New 90-day high: €15.21 Jan 05
Insider recently bought €68k worth of stock Dec 23
AddLife AB (publ) (OM:ALIF B) completed the acquisition of the advanced surgery business of SIAD Healthcare S.p.A. Dec 03
New 90-day low: €11.63 Nov 11
AddLife AB (publ) to Report Nine Months, 2021 Results on Oct 22, 2021 Nov 03
Market pulls back on stock over the past week Oct 30
New 90-day high: €14.96 Oct 27
Third quarter earnings released Oct 22 AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Zafe Care Systems Ab.
AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Ropox A/S. Oct 02 Shareholder Returns 1AD1 DE Life Sciences DE Market 7D -7.8% -3.1% -2.0% 1Y 24.2% -5.9% 6.9%
See full shareholder returns
Return vs Market: 1AD1 exceeded the German Market which returned 6.9% over the past year.
Price Volatility Is 1AD1's price volatile compared to industry and market? 1AD1 volatility 1AD1 Average Weekly Movement 4.8% Life Sciences Industry Average Movement 7.1% Market Average Movement 4.9% 10% most volatile stocks in DE Market 11.3% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: 1AD1 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 1AD1's weekly volatility (5%) has been stable over the past year.
About the Company Founded Employees CEO Website 1906 2,356 Fredrik Dalborg www.add.life
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments.
Show more AddLife AB (publ) Fundamentals Summary How do AddLife's earnings and revenue compare to its market cap? 1AD1 fundamental statistics Market cap €1.45b Earnings (TTM ) €10.17m Revenue (TTM ) €870.21m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 1AD1 income statement (TTM ) Revenue SEK 10.01b Cost of Revenue SEK 6.28b Gross Profit SEK 3.74b Other Expenses SEK 3.62b Earnings SEK 117.00m
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 05, 2025
Earnings per share (EPS) 0.96 Gross Margin 37.31% Net Profit Margin 1.17% Debt/Equity Ratio 95.9%
How did 1AD1 perform over the long term?
See historical performance and comparison Dividends
0.4% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/23 12:58 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources AddLife AB (publ) is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Karl Norén Danske Bank Gustav Berneblad Nordea Markets
Show 0 more analysts 
